Our previous studies have demonstrated that inhibition of survivin function by AAV-mediated survivin mutant or inhibition of survivin expression by antisense oligonucleotide suppress gastric and colon cancer growth [37, 38]. Here, BIRC5 is linked to colonic neoplasm.